Co-immunoprecipitation with Tau isoform-specific antibodies reveals distinct protein interactions and highlights a putative role for 2N Tau in disease

Journal of Biological Chemistry

Volumn 291, Issue 15, 2016, Pages 8173-8188

  Liu, Chang ^a   Song, Xiaomin ^b   Nisbet, Rebecca ^c   Götz, Jürgen ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL MEMBRANES; MASS SPECTROMETRY; MITOCHONDRIA; NEUROLOGY; SIGNAL TRANSDUCTION;

CELL-TO-CELL SIGNALING; CO-IMMUNOPRECIPITATIONS; FUNCTIONAL ENRICHMENTS; MEMBRANE-BOUND PROTEINS; MICROTUBULE ASSOCIATED PROTEIN; NEUROLOGICAL DISEASE; PREFERENTIAL INTERACTION; QUANTITATIVE MASS SPECTROMETRIES;

CELL SIGNALING;

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BETA SYNUCLEIN; MITOCHONDRIAL CREATINE KINASE; SYNAPSIN I; SYNAPTOGYRIN; SYNAPTOGYRIN 3; SYNAPTOPHYSIN; SYNAPTOTAGMIN; SYNTAXIN; SYNTAXIN 1B; TAU PROTEIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN A; ISOPROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL MEMBRANE; CELL ORGANELLE; CONTROLLED STUDY; IMMUNOPRECIPITATION; MITOCHONDRION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; METABOLISM; PATHOLOGY; TAUOPATHY;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS A; APOLIPOPROTEINS E; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEIN ISOFORMS; TAU PROTEINS; TAUOPATHIES;

EID: 84964575878     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.641902     Document Type: Article

References (66)

1. Dehmelt, L., and Halpain, S. (2005) The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6, 204
2. Halpain, S., and Dehmelt, L. (2006) The MAP1 family of microtubuleassociated proteins. Genome Biol. 7, 224
3. Matus, A. (1990) Microtubule-associated proteins and the determination of neuronal form. J. Physiol. 84, 134-137
4. Tashiro, K., Hasegawa, M., Ihara, Y., and Iwatsubo, T. (1997) Somatodendritic localization of phosphorylated Tau in neonatal and adult rat cerebral cortex. Neuroreport 8, 2797-2801
5. Yoshiyama, Y., Lee, V. M., and Trojanowski, J. Q. (2013) Therapeutic strategies for tau-mediated neurodegeneration. J. Neurol. Neurosurg. Psychiatry 84, 784-795
6. Götz, J., Tolnay, M., Barmettler, R., Chen, F., Probst, A., and Nitsch, R. M. (2001) Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur. J. Neurosci. 13, 2131-2140
7. Götz, J., Deters, N., Doldissen, A., Bokhari, L., Ke, Y., Wiesner, A., Schonrock, N., and Ittner, L. M. (2007)Adecade of tau transgenic animal models and beyond. Brain Pathol. 17, 91-103
8. Zempel, H., and Mandelkow, E. (2014) Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 37, 721-732
9. Chen, F., David, D., Ferrari, A., and Götz, J. (2004) Posttranslational modifications of tau-role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 5, 503-515
10. McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., and D'Souza, I. (2008) Tau isoform regulation is region-and cell-specific in mouse brain. J. Comp. Neurol. 511, 788-803
11. Liu, C., and Götz, J. (2013) Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS ONE 8, e84849
12. Allen, R. D., Weiss, D. G., Hayden, J. H., Brown, D. T., Fujiwake, H., and Simpson, M. (1985) Gliding movement of and bidirectional transport along single native microtubules from squid axoplasm: evidence for an active role of microtubules in cytoplasmic transport. J. Cell Biol. 100, 1736-1752
13. Vale, R. D., Schnapp, B. J., Reese, T. S., and Sheetz, M. P. (1985) Organelle, bead, and microtubule translocations promoted by soluble factors from the squid giant axon. Cell 40, 559-569
14. Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H., and Hirokawa, N. (1994) KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79, 1209-1220
15. Trinczek, B., Ebneth, A., Mandelkow, E. M., and Mandelkow, E. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci. 112, 2355-2367
16. McVicker, D. P., Chrin, L. R., and Berger, C. L. (2011) The nucleotidebinding state of microtubules modulates kinesin processivity and the ability of Tau to inhibit kinesin-mediated transport. J. Biol. Chem. 286, 42873-42880
17. Sontag, J. M., Nunbhakdi-Craig, V., White, C. L., 3rd, Halpain, S., and Sontag, E. (2012) The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies. J. Biol. Chem. 287, 14984-14993
18. Brandt, R., and Leschik, J. (2004) Functional interactions of tau and their relevance for Alzheimer's disease. Curr. Alzheimer Res. 1, 255-269
19. Bhaskar, K., Yen, S. H., and Lee, G. (2005) Disease-related modifications in τ affect the interaction between Fyn and Tau. J. Biol. Chem. 280, 35119-35125
20. Götz, J., Xia, D., Leinenga, G., Chew, Y. L., and Nicholas, H. (2013) What renders TAU toxic. Front. Neurol. 4, 72
21. Shaw, A. S., and Filbert, E. L. (2009) Scaffold proteins and immune-cell signalling. Nat. Rev. Immunol. 9, 47-56
22. Tucker, K. L., Meyer, M., and Barde, Y. A. (2001) Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29-37
23. Dulbecco, R., and Vogt, M. (1954) Plaque formation and isolation of pure lines with poliomyelitis viruses. J. Exp. Med. 99, 167-182
24. Ullrich, M., Liang, V., Chew, Y. L., Banister, S., Song, X., Zaw, T., Lam, H., Berber, S., Kassiou, M., Nicholas, H. R., and Götz, J. (2014) Bio-orthogonal labeling as a tool to visualize and identify newly synthesized proteins in Caenorhabditis elegans. Nat. Protoc. 9, 2237-2255
25. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
26. Dayon, L., and Sanchez, J. C. (2012) Relative protein quantification by MS/MS using the tandem mass tag technology. Methods Mol. Biol. 893, 115-127
27. Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Ohshima, T., Sato-Yoshitake, R., Takei, Y., Noda, T., and Hirokawa, N. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488-491
28. Savitski, M. M., Mathieson, T., Zinn, N., Sweetman, G., Doce, C., Becher, I., Pachl, F., Kuster, B., and Bantscheff, M. (2013) Measuring and managing ratio compression for accurate iTRAQ/TMT quantification. J. Proteome Res. 12, 3586-3598
29. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
30. Pooler, A. M., and Hanger, D. P. (2010) Functional implications of the association of tau with the plasma membrane. Biochem. Soc. Trans. 38, 1012-1015
31. Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., Eckert, A., Staufenbiel, M., Hardeman, E., and Götz, J. (2010) Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142, 387-397
32. Xia, D., and Götz, J. (2014) Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn. Front. Mol. Neurosci. 7, 40
33. Farah, C. A., Liazoghli, D., Perreault, S., Desjardins, M., Guimont, A., Anton, A., Lauzon, M., Kreibich, G., Paiement, J., and Leclerc, N. (2005) Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons. J. Biol. Chem. 280, 9439-9449
34. Farah, C. A., Perreault, S., Liazoghli, D., Desjardins, M., Anton, A., Lauzon, M., Paiement, J., and Leclerc, N. (2006) Tau interacts with Golgi membranes and mediates their association with microtubules. Cell Motil. Cytoskeleton 63, 710-724
35. Brandt, R., Léger, J., and Lee, G. (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340
36. Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., and Iijima, K. M. (2012) Loss of axonal mitochondria promotes taumediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. PLoS Genet. 8, e1002918
37. Reddy, P. H. (2014) Misfolded proteins, mitochondrial dysfunction, and neurodegenerative diseases. Biochim. Biophys. Acta 1842, 1167
38. DuBoff, B., Götz, J., and Feany, M. B. (2012) Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75, 618-632
39. Kopeikina, K. J., Carlson, G. A., Pitstick, R., Ludvigson, A. E., Peters, A., Luebke, J. I., Koffie, R. M., Frosch, M. P., Hyman, B. T., and Spires-Jones, T. L. (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am. J. Pathol. 179, 2071-2082
40. Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., and Brinton, R. D. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 106, 14670-14675
41. Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Dröse, S., Brandt, U., Savaskan, E., Czech, C., Götz, J., and Eckert, A. (2009) Amyloid-β and τ synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U.S.A. 106, 20057-20062
42. David, S., Shoemaker, M., and Haley, B. E. (1998) Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Res. Mol. Brain Res. 54, 276-287
43. Roberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G. Q., Palop, J. J., Noebels, J. L., and Mucke, L. (2011) Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on τ levels in multiple mouse models of Alzheimer's disease. J. Neurosci. 31, 700-711
44. Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L. L., Ashe, K. H., and Liao, D. (2010) τ mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081
45. Hashiguchi, M., Sobue, K., and Paudel, H. K. (2000) 14-3-3ζ is an effector of tau protein phosphorylation. J. Biol. Chem. 275, 25247-25254
46. Pozuelo Rubio, M., Geraghty, K. M., Wong, B. H., Wood, N. T., Campbell, D. G., Morrice, N., and Mackintosh, C. (2004) 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem. J. 379, 395-408
47. Chen, B. S., and Roche, K. W. (2009) Growth factor-dependent trafficking of cerebellar NMDA receptors via protein kinase B/Akt phosphorylation of NR2C. Neuron 62, 471-478
48. Fernández, E., Collins, M. O., Uren, R. T., Kopanitsa, M. V., Komiyama, N. H., Croning, M. D., Zografos, L., Armstrong, J. D., Choudhary, J. S., and Grant, S. G. (2009) Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol. Syst. Biol. 5, 269
49. Angrand, P. O., Segura, I., Völkel, P., Ghidelli, S., Terry, R., Brajenovic, M., Vintersten, K., Klein, R., Superti-Furga, G., Drewes, G., Kuster, B., Bouwmeester, T., and Acker-Palmer, A. (2006) Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol. Cell. Proteomics 5, 2211-2227
50. Bloom, O., Evergren, E., Tomilin, N., Kjaerulff, O., Löw, P., Brodin, L., Pieribone, V. A., Greengard, P., and Shupliakov, O. (2003) Colocalization of synapsin and actin during synaptic vesicle recycling. J. Cell Biol. 161, 737-747
51. Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., and Feany, M. B. (2007) Abnormal bundling and accumulation of F-actin mediates τ-induced neuronal degeneration in vivo. Nat. Cell Biol. 9, 139-148
52. Galas, M. C., Chasserot-Golaz, S., Dirrig-Grosch, S., and Bader, M. F. (2000) Presence of dynamin-syntaxin complexes associated with secretory granules in adrenal chromaffin cells. J. Neurochem. 75, 1511-1519
53. Mishima, T., Fujiwara, T., Sanada, M., Kofuji, T., Kanai-Azuma, M., and Akagawa, K. (2014) Syntaxin 1B, but not syntaxin 1A, is necessary for the regulation of synaptic vesicle exocytosis and of the readily releasable pool at central synapses. PLoS ONE 9, e90004
54. Garringer, H. J., Murrell, J., Sammeta, N., Gnezda, A., Ghetti, B., and Vidal, R. (2013) Increased τ phosphorylation and τ truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice. PLoS ONE 8, e56426
55. Xia, D., Li, C., and Götz, J. (2015) Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. Biochim. Biophys. Acta 1852, 913-924
56. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., and Alberts, M. J. (1993) Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472
57. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991) apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166
58. Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., and Roses, A. D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 11183-11186
59. Roher, A. E., Maarouf, C. L., Sue, L. I., Hu, Y., Wilson, J., and Beach, T. G. (2009) Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers 14, 493-501
60. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815
61. Li, J-Y., Henning Jensen, P., and Dahlström, A. (2002) Differential localization of α-, β-and γ-synucleins in the rat CNS. Neuroscience 113, 463-478
62. Benussi, L., Ghidoni, R., Paterlini, A., Nicosia, F., Alberici, A. C., Signorini, S., Barbiero, L., and Binetti, G. (2005) Interaction between τ and α-sy-nuclein proteins is impaired in the presence of P301L τ mutation. Exp. Cell Res. 308, 78-84
63. Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., and Lee, V. M. (2003) Initiation and synergistic fibrillization of τ and α-synuclein. Science 300, 636-640
64. Badiola, N., de Oliveira, R. M., Herrera, F., Guardia-Laguarta, C., Gonçalves, S. A., Pera, M., Suárez-Calvet, M., Clarimon, J., Outeiro, T. F., and Lleó, A. (2011) Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE 6, e26609
65. Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., Patterson, C., Dickson, D. W., Nahman, N. S., Jr., Hutton, M., Burrows, F., and Petrucelli, L. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated τ client proteins. J. Clin. Invest. 117, 648-658
66. Salminen, A., Ojala, J., Kaarniranta, K., Hiltunen, M., and Soininen, H. (2011) Hsp90 regulates τ pathology through co-chaperone complexes in Alzheimer's disease. Prog. Neurobiol. 93, 99-110